
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 4.200 | 4.360 | 0.160 |
Shares | 95.800 | 95.800 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 15.984 | 16.724 |
Price to Book | 2.316 | 2.476 |
Price to Sales | 1.684 | 1.764 |
Price to Cash Flow | 12.273 | 12.092 |
Dividend Yield | 2.943 | 2.902 |
5 Years Earnings Growth | 8.102 | 9.458 |
Name | Net % | Category Average |
---|---|---|
Industrials | 39.940 | 33.568 |
Healthcare | 16.390 | 14.989 |
Financial Services | 14.410 | 17.803 |
Technology | 12.230 | 9.132 |
Consumer Defensive | 9.280 | 7.863 |
Consumer Cyclical | 3.980 | 5.953 |
Basic Materials | 3.760 | 6.134 |
Number of long holdings: 37
Number of short holdings: 14
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Novo Nordisk B | DK0062498333 | 6.40 | 420.3 | +2.64% | |
Sandvik AB | SE0000667891 | 5.52 | 182.70 | -1.22% | |
SEB A | SE0000148884 | 5.38 | 137.30 | +0.70% | |
Volvo B | SE0000115446 | 4.98 | 241.70 | +0.71% | |
Hexagon B | SE0015961909 | 4.62 | 84.89 | -10.80% | |
Kesko | FI0009000202 | 4.49 | 18.67 | +0.86% | |
DnB | NO0010161896 | 4.35 | 249.50 | +0.44% | |
Essity B | SE0009922164 | 4.34 | 276.50 | +1.24% | |
AstraZeneca | GB0009895292 | 4.29 | 10,008.0 | -0.10% | |
Beijer Ref | SE0015949748 | 4.07 | 137.10 | +0.22% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
SE0011309681 | 11.88B | -6.40 | 6.40 | 8.31 | ||
Handelsbanken Global Tema A1 EUR | 4.23B | -10.76 | 1.95 | 7.72 | ||
Sverige Selektiv A1 EUR | 2.45B | 6.11 | 7.61 | 9.17 | ||
Handelsbanken Sverige Selektiv A9 E | 2.45B | 6.35 | 8.58 | 10.14 | ||
Nordiska Smabolag A1 EUR | 2.42B | 2.70 | -4.05 | 7.66 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review